Interaction of PPARα With the Canonic Wnt Pathway in the Regulation of Renal Fibrosis.
about
Novel Anti-fibrotic Therapies.PGC1α in the kidney.Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation.Activation of PPARα by clofibrate sensitizes pancreatic cancer cells to radiation through the Wnt/β-catenin pathway.Structure-guided evolution of a 2-phenyl-4-carboxyquinoline chemotype into PPARα selective agonists: New leads for oculovascular conditions.Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context
P2860
Interaction of PPARα With the Canonic Wnt Pathway in the Regulation of Renal Fibrosis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Interaction of PPARα With the Canonic Wnt Pathway in the Regulation of Renal Fibrosis.
@en
Interaction of PPARα With the Canonic Wnt Pathway in the Regulation of Renal Fibrosis.
@nl
type
label
Interaction of PPARα With the Canonic Wnt Pathway in the Regulation of Renal Fibrosis.
@en
Interaction of PPARα With the Canonic Wnt Pathway in the Regulation of Renal Fibrosis.
@nl
prefLabel
Interaction of PPARα With the Canonic Wnt Pathway in the Regulation of Renal Fibrosis.
@en
Interaction of PPARα With the Canonic Wnt Pathway in the Regulation of Renal Fibrosis.
@nl
P2093
P2860
P356
P1433
P1476
Interaction of PPARα With the Canonic Wnt Pathway in the Regulation of Renal Fibrosis.
@en
P2093
Jian-Xing Ma
Yusuke Takahashi
P2860
P304
P356
10.2337/DB16-0426
P407
P50
P577
2016-08-19T00:00:00Z